Stem Cell Therapy Shows Promise for Diabetic Foot Ulcers

Diabetes can affect nearly every part of the body. Over time, uncontrolled blood sugar levels can damage blood vessels and nerves, leading to serious complications.

One of the most challenging is the diabetic foot ulcer (DFU), an open wound that typically develops on the foot. Poor circulation and nerve damage often make these wounds difficult to heal.

DFUs affect an estimated 15 percent of people with diabetes. In severe cases, they can lead to infection, amputation, and significant loss of mobility.

Current treatment options often provide limited benefit, especially for patients with chronic, non-healing ulcers.

New research suggests stem cell therapy may offer another option.

A New Stem Cell Approach for Diabetic Foot Ulcers

Researchers in Nicaragua evaluated a stem cell therapy designed to improve blood flow and promote wound healing.

The treatment uses stem cells obtained from a patient’s own fat tissue. The team isolated a mixture of regenerative cells and injected them directly into the ulcer.

Researchers hoped the therapy would help restore damaged blood vessels, improve circulation, and stimulate tissue repair.

Earlier pilot studies produced encouraging results.

After 18 months, researchers reported complete wound healing along with a favorable safety profile. Follow-up data collected six years later showed that several patients continued to experience lasting benefits.

Promising Results in Patients Facing Amputation

The larger study enrolled 63 patients between 35 and 70 years of age.

All participants had Type 2 diabetes and chronic foot ulcers that had failed to heal. Physicians had identified every participant as a potential amputation candidate.

Researchers treated each patient with stem cells derived from their own fat tissue.

The results were encouraging.

Six months after treatment:

  • Fifty-one patients achieved complete ulcer closure.
  • Eight patients achieved more than 75 percent wound closure.
  • Only three patients required early amputation.
  • One patient died from causes unrelated to the study.

Twelve months after treatment:

  • Fifty patients maintained complete wound healing.
  • Four patients achieved more than 85 percent healing.

These outcomes suggest the therapy may help restore tissue function and promote substantial wound repair in patients with few remaining treatment options.

Advancing Regenerative Medicine for Chronic Wounds

The findings have attracted attention from experts in regenerative medicine.

Dr. Anthony Atala, Director of the Wake Forest Institute for Regenerative Medicine, called the results worthy of further investigation.

“This work should be reviewed as it demonstrates the possibility of a novel cell injection therapy that can alleviate pain and infection, accelerate wound healing, and possibly avoid amputation,” he said.

Avoiding amputation remains one of the most important goals in diabetic foot ulcer care. Amputations can dramatically affect quality of life and often lead to additional health complications.

By helping wounds heal and improving blood flow, stem cell therapies may offer a new strategy for preserving mobility and independence.

Looking Ahead

The study adds to growing evidence that regenerative medicine may help treat chronic wounds that resist conventional therapies.

Researchers must still conduct larger, controlled studies to confirm safety and effectiveness. They must also determine which patients are most likely to benefit.

Even so, the results offer hope for people living with diabetic foot ulcers and for clinicians seeking better treatment options.

If future studies confirm these findings, stem cell therapies could become an important tool for reducing amputations and improving outcomes for patients with diabetes.

The findings were published in Stem Cells Translational Medicine.

2 thoughts on “Stem Cell Therapy Shows Promise for Diabetic Foot Ulcers”

  1. Most diabetes patients have foot ulcers attributed by many factors such as lack of feeling in the foot, poor circulation, foot deformities and irritation. Patients with diabetes for many years tend to develop neuropathy which might affects an individual to reduce or lose the ability of feeling pain in the foot. The high blood glucose is a sole factor to cause the damage of nerve cells and trigger no pain in the foot. It also reduced the body ability to fight off a potency infection and wound healing.

    Recent clinical trial by injecting autologous adipose derived stromal vascular fraction (SVF) cells to treat no healing DFUs. The results showed that majority of patients have ulcer closure, vascular repair and angiogeness after 6-12 months of treatment.

    SVF is a by product of adipose harvesting of excess fatty tissue. This fraction is enriched with adipose derived stem cells which are capable of multilineage differentiation. SVF stem cells have been used in patients with various autoimmune, urological, neurological, pulmonary, ophthalmologist and orthopedic application. Therefore, SVF of adipose tissue is a potent source of preadipocytes mesenchyma stem cells to regenerate T cells, B cells, endothelial progenitor cells and adipose tissue macrophages. Those adipose stem cells are able to secret cytokines, chemokines and growth factors which stimulate wound healing, tissue regeneration and vascularization. Most injected SVF adipose derived stem cells can attach to the lesion and survive for long periods of time. Thus, SVF derived stem cells is an important clinical setting stem cells for multiple clinical applications. However, the amount of growth factors secretion from adipose SVF progenitors is insufficient and take longer period of time for regeneration. The addition of exogenous growth factors may give additional advantage to speed up the process of wound healing and repairing of tissues.

  2. Your research will help thousands of people. How’s your progress with curing or better management of Diabetes? Type 1 in particular. Stem cell and genetic manipulation is the only way forward. More progress and faster results need to be undertaken. 15% of countries budgets are spent due to Diabetes and the various side effects caused by this disease.
    Some of the research and findings resulting from Covid19 pandemic are available and can be used to cure Diabetes.
    Thanks very much.

Leave a Reply